Cargando…
Duodenal‐jejunal bypass liner for the treatment of type 2 diabetes and obesity: 3‐year outcomes in the First National Health Service (NHS) EndoBarrier Service
Autores principales: | Ryder, Robert E. J., Yadagiri, Mahi, Burbridge, Wyn, Irwin, Susan P., Gandhi, Hardeep, Bashir, Tahira, Allden, Rachael A., Wyres, Melanie, Cull, Melissa, Bleasdale, John P., Fogden, Edward N., Anderson, Mark R., Sen Gupta, Piya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313821/ https://www.ncbi.nlm.nih.gov/pubmed/35285080 http://dx.doi.org/10.1111/dme.14827 |
Ejemplares similares
-
The EndoBarrier: Duodenal-Jejunal Bypass Liner for Diabetes and Weight Loss
por: Ruban, Aruchuna, et al.
Publicado: (2018) -
Effect of the EndoBarrier Gastrointestinal Liner on obesity and type 2 diabetes: protocol for systematic review and meta-analysis of clinical studies
por: Rohde, Ulrich, et al.
Publicado: (2013) -
EndoBarrier®: a Safe and Effective Novel Treatment for Obesity and Type 2 Diabetes?
por: Patel, Nisha, et al.
Publicado: (2018) -
EndoBarrier™ Implantation Rapidly Improves Insulin Sensitivity in Obese Individuals with Type 2 Diabetes Mellitus
por: Obermayer, Anna, et al.
Publicado: (2021) -
Endoscopic Duodenal-Jejunal Bypass Liner Treatment for Type 2 Diabetes and Obesity: Glycemic and Cardiovascular Disease Risk Factor Improvements in 1,022 Patients Treated Worldwide
por: Ryder, Robert E.J., et al.
Publicado: (2023)